Fostamatinib for Hospitalized Adults With COVID-19

NCT04579393 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

59

Enrollment

NIH

Sponsor class

Conditions

Coronavirus Disease 2019

Interventions

DRUG: Placebo
DRUG: fostamatinib

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)